QUICK LINKS:

EFS

Gene-to-Protein & Gene-to-Structure

Viva Engine for Lead Discovery

Membrane Protein Targeted Discovery Technology

请拖入内容到容器

EFS

Gene-to-Protein & Gene-to-Structure

Viva Biotech is the world's top CRO specialized in ...

Viva Engine for Lead Discovery

A unique platform for drug lead discovery from target to drug candidates consisting of:
请拖入内容到容器

Antibody

Viva is devoted to pushing the boundary of GPCR protein studies. Working closely with experienced experts from GPCR field, well trained researchers in Viva Biotech are able to deliver top quality Cry
View details

Cell Lines

GPCR cell lines developed in-house are ready for distribution and assay screening services.
View details

Crystal Structures

Crystal structures developed in-house are ready for distribution, which can be used for compound soaking.
View details
请拖入内容到容器
As Both Investor and CRO, Viva Enjoys Another Fruitful Year at JPM
San Francisco, January 13 to 16, 2020 - The 38th annual J.P. Morgan Healthcare Conference was held in San Francisco alongside an abundance of related investment, innovation, and research conferences (
Viva Biotech Awarded ‘Top 10 Public Companies’ Fostering Value Creation and Discoveries of Innovative Drugs from 0 to 1
(Beijing, 20-22 Dec 2019) The ‘Future Healthcare VB 100 Summit’ organized by VCBeat and VCBeat Research was held in Beijing. Viva Biotech was invited to the Summit and awarded the ‘Top 10 Public Compa
Innovation| Partnership| Growth Viva Biotech Partnership Summit Successfully Launched in Shanghai
Innovation| Partnership| Growth Viva Biotech Partnership Summit Successfully Launched in Shanghai
请拖入内容到容器